Press Releases

Ceapro Announces Results of 2021 Shareholders’ Meeting

June 1, 2021

Ceapro Inc. Announces Completion of Patient Enrollment in Clinical Study Evaluating Beta Glucan as a Cholesterol-Lowering Agent

May 26, 2021

Ceapro Inc. Reports 2021 First Quarter Financial Results and Highlights

May 20, 2021

Ceapro Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

April 22, 2021

Ceapro Inc. Announces Successful Completion of Collaborative Research and Development Program with University of Alberta

April 8, 2021

Ceapro Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

March 3, 2021

Ceapro Inc. to Present at NobleCon17

January 14, 2021

Ceapro Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference

January 8, 2021